XML 73 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
Earnings Per Common Share
3 Months Ended
Mar. 31, 2013
Earnings Per Common Share

2. Earnings Per Common Share

Basic earnings per common share are calculated by dividing net income by the weighted average number of common shares outstanding during the period. Diluted earnings per common share adjust basic earnings per share for the effects of potentially dilutive common shares. Potentially dilutive common shares include the dilutive effects of shares issuable under our equity compensation plans, including stock options and restricted stock, and, for the three months ended March 31, 2012, shares issuable upon the potential conversion of our 33/4% senior subordinated convertible notes that were due on July 15, 2012 (“Convertible Notes”), each using the treasury stock method. In addition, the conversion feature of our Convertible Notes had a dilutive effect on our earnings per share for the three months ended March 31, 2012, assuming the conversion premium was converted into common stock based on the average closing price per share of our stock during the period, because the average closing price per share of our common stock for such periods was above the conversion price of the Convertible Notes of $31.25 per share.

 

     Three Months Ended
March 31,
 
     2013      2012  

Numerator—basic and diluted

     

Net income

   $ 23,680       $ 18,431   
  

 

 

    

 

 

 

Denominator

     

Weighted average number of common shares outstanding—basic

     39,403         40,358   

Effect of dilutive stock options

     595         963   

Effect of dilutive convertible notes

     —           1,159   

Effect of dilutive restricted shares

     622         705   
  

 

 

    

 

 

 

Weighted average number of common shares outstanding—diluted

     40,620         43,185   
  

 

 

    

 

 

 

Earnings per common share—basic

   $ 0.60       $ 0.46   
  

 

 

    

 

 

 

Earnings per common share—diluted

   $ 0.58       $ 0.43   
  

 

 

    

 

 

 

Antidilutive stock options and restricted shares

     3,486         2,081